Is Wave Life Sciences Ltd. (WVE) a Buy, Sell, or Hold?
NASDAQ : WVE
Wave Life Sciences Ltd. — Institutional Ownership
$5.51 USD
-$0.25 (-4.34%)
- Volume
- 2.87M
- Average Volume
- 3.36M
- Market Capitalization
- $1.06B
- P/E Ratio
- -5.06
- Dividend Yield
- 0.00%
- Price Target
- $14.50
- Year High
- $21.73
- Year Low
- $5.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.13
Institutional Ownership Summary
Institutional Ownership %
1.59%
Investors Holding
38
change: -215 | last: 253
Increased Positions
24
change: -132 | last: 156
Reduced Positions
7
change: -44 | last: 51
New Positions
11
change: -39 | last: 50
Sold Positions
206
change: 169 | last: 37
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -31.4743 | last: 0.3147
Total Invested
18.52M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-13 | Adage Capital Management, L.P. | 1M | 0.53% |
| 2026-05-06 | FMR LLC | 5.19M | 2.80% |
| 2026-04-17 | RA Capital Healthcare Fund, L.P. | 34.07M | 17.10% |
| 2026-04-17 | RA Capital Management, L.P. | 34.23M | 17.10% |
| 2026-04-17 | Peter Kolchinsky | 34.23M | 17.10% |
| 2026-04-17 | Rajeev Shah | 34.23M | 17.10% |
| 2026-03-30 | RA Capital Healthcare Fund, L.P. | 34.07M | 17.40% |
| 2026-03-30 | RA Capital Management, L.P. | 34.23M | 17.50% |
| 2026-03-30 | Peter Kolchinsky | 34.23M | 17.50% |
| 2026-03-30 | Rajeev Shah | 34.23M | 17.50% |
| 2026-02-12 | Adage Capital Management, L.P. | 9.79M | 5.35% |
| 2026-02-05 | FMR LLC | 15.02M | 8.50% |
| 2025-12-15 | RA Capital Management, L.P. | 25.45M | 13.40% |
| 2025-12-15 | RA Capital Healthcare Fund, L.P. | 25.3M | 13.30% |
| 2025-12-15 | Rajeev Shah | 25.45M | 13.40% |
| 2025-12-15 | Peter Kolchinsky | 25.45M | 13.40% |
| 2025-11-13 | Peter Kolchinsky | 25.45M | 14.60% |
| 2025-11-13 | Rajeev Shah | 25.45M | 14.60% |
| 2025-11-13 | RA Capital Management, L.P. | 25.45M | 14.60% |
| 2025-11-13 | RA Capital Healthcare Fund, L.P. | 25.3M | 14.50% |
| 2025-08-12 | Adage Capital Management, L.P. | 15.02M | 9.65% |
| 2025-05-12 | Adage Capital Management, L.P. | 12.52M | 8.15% |
| 2025-02-14 | Maverick Capital, Ltd. | 8.26M | 5.40% |
| 2025-02-05 | BlackRock, Inc. | 9.36M | 6.10% |
| 2024-10-18 | (1)Names of reporting persons. BlackRock, Inc. | 7.3M | 5.00% |
| 2023-01-30 | GSK plc | 10.68M | 10.95% |
| 2022-12-22 | Phillip Gross | 5.53M | 6.36% |
| 2022-12-22 | Robert Atchinson | 5.53M | 6.36% |
| 2022-12-22 | Adage Capital Partners GP, L.L.C. | 5.53M | 6.36% |
| 2022-12-22 | Adage Capital Partners, L.P. | 5.53M | 6.36% |
| 2022-12-22 | Adage Capital Advisors, L.L.C. | 5.53M | 6.36% |
| 2022-05-26 | 683 Capital Partners, LP | 3.63M | 5.90% |
| 2022-05-26 | Ari Zweiman | 3.63M | 5.90% |
| 2022-05-26 | 683 Capital Management, LLC | 3.63M | 5.90% |
| 2022-02-14 | Ltd. – 75-2482446 | 5.59M | 9.50% |
| 2022-02-14 | III | 5.59M | 9.50% |
| 2022-02-14 | 75-2686461 | 5.59M | 9.50% |
| 2021-10-29 | M28 Capital Management LP | 3.77M | 7.20% |
| 2021-04-09 | Deerfield Management Company, L.P. | 3.91M | 7.98% |
| 2021-04-09 | Deerfield Mgmt, L.P. | 3.91M | 7.98% |
| 2021-04-09 | James E. Flynn | 3.91M | 7.98% |
| 2021-04-09 | Deerfield Partners, L.P. | 3.91M | 7.98% |
| 2021-02-16 | Nantahala Capital Management, LLC | 3.36M | 6.90% |
| 2021-02-16 | Daniel Mack | 3.36M | 6.90% |
| 2021-02-16 | Wilmot B. Harkey | 3.36M | 6.90% |
| 2021-02-12 | Morgan Stanley | 1.25M | 2.60% |
| 2021-02-12 | Morgan Stanley Capital Services LLC | 1.22M | 2.50% |
| 2020-08-24 | Morgan Stanley Capital Services LLC | 1.93M | 5.30% |
| 2020-08-24 | Morgan Stanley | 1.95M | 5.30% |
| 2020-01-28 | Wellington Management Group LLP | 3.21M | 9.35% |
| 2020-01-28 | Wellington Group Holdings LLP | 3.21M | 9.35% |
| 2020-01-28 | Wellington Management Company LLP | 3.04M | 8.86% |
| 2020-01-28 | Wellington Investment Advisors Holdings LLP | 3.21M | 9.35% |
| 2019-12-23 | Biotech Target N.V. | 1.9M | 5.50% |
| 2019-12-23 | BB Biotech AG | 1.9M | 5.50% |
| 2019-02-14 | Redmile Group, LLC | 2.24M | 7.60% |
| 2019-02-14 | Jeremy C. Green | 2.24M | 7.60% |
| 2019-02-13 | First Trust Portfolios L.P., First Trust Advisors L.P., The Charger Corporation | 2.71M | 5.98% |
| 2018-06-29 | Joe Lewis | 1.59M | 5.50% |
| 2018-06-29 | Boxer Capital, LLC | 1.59M | 5.50% |
| 2018-06-29 | Boxer Asset Management Inc. | 1.59M | 5.50% |
| 2018-02-14 | 52-0556948 | 1.73M | 6.20% |
| 2018-02-14 | JEREMY C. GREEN | 2.21M | 7.95% |
| 2018-02-14 | Redmile Group, LLC | 2.21M | 7.95% |
| 2016-05-12 | ( 98-0182045 | 1.88M | 11.00% |
| 2016-05-12 | ( 13-5315170 | 1.88M | 11.00% |
| 2016-05-12 | ( 52-2090275 | 1.88M | 11.00% |
| 2016-05-12 | 52-2090292 | 1.88M | 11.00% |
| 2015-12-10 | Teva Pharmaceutical Industries Limited (98-0478099) | 1.88M | 9.00% |
| 2015-12-10 | Teva Pharmaceuticals USA, Inc. (22-1734359) | 1.88M | 9.00% |
| 2015-11-19 | Foresite Capital Fund III, L.P. (“FCF III”) | 1.33M | 6.40% |
| 2015-11-19 | Foresite Capital Management III, LLC (“FCM III”) | 1.33M | 6.40% |
| 2015-11-19 | James Tananbaum (“Tananbaum”) | 1.33M | 6.40% |
WVE Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $17.00 | 168.65M | $2.87B | $602.07M | $17.77M | $2.28B |
| 2024-12-31 | $12.37 | 138.28M | $1.71B | $302.08M | $25.4M | $1.43B |
| 2023-12-31 | $5.05 | 106.1M | $535.79M | $200.35M | $32.12M | $367.56M |
| 2022-12-31 | $7.00 | 78.86M | $551.99M | $88.5M | $37.61M | $501.11M |
| 2021-12-31 | $3.14 | 51.83M | $162.73M | $150.56M | $29.92M | $42.08M |
| 2020-12-31 | $7.87 | 39.23M | $308.72M | $184.5M | $29.3M | $153.53M |
| 2019-12-31 | $8.02 | 33.87M | $271.61M | $147.16M | $32.55M | $157M |
| 2018-12-31 | $42.04 | 28.97M | $1.22B | $174.82M | $10.4M | $1.05B |
| 2017-12-31 | $35.10 | 26.51M | $930.62M | $142.5M | $3.45M | $791.57M |
| 2016-12-31 | $26.15 | 22.8M | $596.24M | $150.29M | $78000 | $446.02M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.81 | 202.1M | $1.17B | $368.01M | $43.59M | $849.78M |
| 2026-03-31 | $7.25 | 200.17M | $1.45B | $544.59M | $15.72M | $922.34M |
| 2025-12-31 | $17.00 | 180.15M | $3.06B | $602.07M | $17.77M | $2.48B |
| 2025-09-30 | $7.32 | 167.74M | $1.23B | $196.22M | $19.77M | $1.05B |
| 2025-06-30 | $6.50 | 163.99M | $1.07B | $208.48M | $21.71M | $879.15M |
| 2025-03-31 | $8.08 | 162.53M | $1.31B | $243.08M | $23.6M | $1.09B |
| 2024-12-31 | $12.37 | 161.49M | $2B | $302.08M | $25.4M | $1.72B |
| 2024-09-30 | $8.20 | 131.45M | $1.08B | $310.95M | $27.17M | $794.09M |
| 2024-06-30 | $5.24 | 129.53M | $678.72M | $153.96M | $28.88M | $553.64M |
| 2024-03-31 | $6.31 | 129.27M | $815.7M | $180.92M | $30.53M | $665.32M |
| 2023-12-31 | $5.05 | 109.63M | $553.62M | $200.35M | $32.12M | $385.39M |
| 2023-09-30 | $5.75 | 106.03M | $609.64M | $139.94M | $33.67M | $503.37M |